Axogen (AXGN) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -818.00 |
| Dec 31, 2025 | -905.00 |
| Sep 30, 2025 | -641.00 |
| Jun 30, 2025 | -50.00 |
| Mar 31, 2025 | -821.00 |
| Dec 31, 2024 | -661.00 |
| Sep 30, 2024 | -930.00 |
| Jun 30, 2024 | -1,033.00 |
| Mar 31, 2024 | -522.00 |
| Dec 31, 2023 | -986.00 |
| Sep 30, 2023 | -789.00 |
| Jun 30, 2023 | -720.00 |
| Mar 31, 2023 | -657.00 |
| Dec 31, 2022 | -1,714.00 |
| Sep 30, 2022 | -111.00 |
| Jun 30, 2022 | -323.00 |
| Mar 31, 2022 | -223.00 |
| Dec 31, 2021 | -117.00 |
| Sep 30, 2021 | -164.00 |
| Jun 30, 2021 | -634.00 |
| Mar 31, 2021 | 66.00 |
| Dec 31, 2020 | 131.00 |
| Sep 30, 2020 | 26.00 |
| Jun 30, 2020 | -914.00 |
| Mar 31, 2020 | 0.00 |
| Dec 31, 2019 | 263.00 |
| Sep 30, 2019 | 340.00 |
| Jun 30, 2019 | 517.00 |
| Mar 31, 2019 | 640.00 |
| Dec 31, 2018 | 444.00 |
| Sep 30, 2018 | 670.00 |
| Jun 30, 2018 | 704.00 |
| Mar 31, 2018 | 1,043.00 |
| Dec 31, 2017 | 800.00 |
| Sep 30, 2017 | 1,177.00 |
| Jun 30, 2017 | 993.00 |
| Mar 31, 2017 | 1,091.00 |
| Dec 31, 2016 | 2,311.00 |
| Sep 30, 2016 | 8,394.00 |
| Jun 30, 2016 | 1,984.00 |
| Mar 31, 2016 | 1,288.00 |
| Dec 31, 2015 | 8,610.00 |
| Sep 30, 2015 | 278.00 |